To access this element change to forms mode OFF
Grant Award View - GA30211
Targeting Cell Death Pathways in Malignant Mesothelioma
GA ID:
GA30211
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$463,058.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Targeting Cell Death Pathways in Malignant Mesothelioma
Purpose:
Malignant mesothelioma (MM) is an aggressive and incurable cancer with median patient survival of 12 months. By screening a panel of MM cell lines against a new class of drugs that directly target the natural cell death mechanisms in tumour cells, we identified two specific 'survival factors' in MM. Co-targeting of these molecules leads to potent MM cell killing. The proposed research will expand these studies into animal model of MM and potentially provide new treatment options for MM patients.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1157551
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
La Trobe University
Recipient ABN:
64 804 735 113
Grant Recipient Location
Suburb:
Bundoora
Town/City:
Bundoora
Postcode:
3083
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA